论文部分内容阅读
目的:探讨4种常用ACEI对原发性高血压所产生的经济效果。方法:本文对229例原发性高血压病人所用的4种ACEI即:卡托普利(captopril),依那普利(cnalapril),贝那普利(benazepril)和培哚普利(perindopril)进行回顾性的分析评价,用成本效果分析方法进行比较。结果:贝那普利为最佳SBP降压药物,培哚普利为最佳DBP降压药物。结论:通过分析说明了药物经济学在指导合理用药,减轻病人经济负担,提高社会经济效益和指导新药开发方面具有重要作用,以便利用有限的医药资源,产生尽可能好的社会和经济效益
Objective: To investigate the economic effects of four common ACEIs on essential hypertension. METHODS: Four ACEIs used in 229 patients with essential hypertension, namely captopril, cnalapril, benazepril and perindopril, Retrospective analysis and evaluation, using cost-effectiveness analysis methods for comparison. Results: Benazepril was the best SBP antihypertensive drug and perindopril was the best DBP antihypertensive drug. Conclusion: Through the analysis, it shows that pharmacoeconomics plays an important role in guiding the rational use of drugs, reducing the economic burden on patients, improving social and economic benefits and guiding the development of new drugs so as to make the best use of limited medical resources to produce the best possible social and economic benefits